2021-01-08,AVROBIO to Present at the ICR Conference 2021
2021-01-07,AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-12-16,Is AVRO A Good Stock To Buy Now?
2020-12-04,AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2020-11-24,AVROBIO Announces Closing of Underwritten Public Offering
2020-11-19,AVROBIO Announces Pricing of Underwritten Public Offering of $75 Million of Common Stock
2020-11-19,AVROBIO Announces Proposed Public Offering of Common Stock
2020-11-17,"AVROBIO Announces New Positive Clinical Data and Preclinical Data, as Well as Expanded Leading Lysosomal Disorder Gene Therapy Pipeline"
2020-11-06,AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-11-05,AVROBIO Reports Third Quarter 2020 Financial Results and Provides Business Update
2020-11-05,Here's Why We're Not Too Worried About AVROBIO's (NASDAQ:AVRO) Cash Burn Situation
2020-10-29,"AVROBIO Receives Orphan Drug Designation from the European Commission for AVRRD01, an Investigational Gene Therapy for Fabry Disease"
2020-10-26,AVROBIO to Share Clinical and Pipeline Updates at Virtual R&D Day
2020-10-21,AVROBIO Appoints Dr. Gail Farfel to its Board of Directors
2020-10-06,AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-10-05,AVROBIO Expands Lentiviral Gene Therapy Pipeline with Program for Hunter Syndrome
2020-09-29,AVROBIO's Gaucher Disease Candidate Gets Orphan Drug Status
2020-09-28,"AVROBIO Receives Orphan Drug Designation from the European Medicines Agency for AVR-RD-02, an Investigational Gene Therapy for Gaucher Disease"
2020-09-25,AVROBIO to Present at Two Upcoming Investor Conferences
2020-09-04,AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2020-09-03,AVROBIO to Present at Three Upcoming Investor Conferences
2020-08-12,"Did Hedge Funds Make The Right Call On AVROBIO, Inc. (AVRO) ?"
2020-08-07,AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-08-06,AVROBIO Reports Second Quarter 2020 Financial Results and Provides Business Update
2020-08-05,AVROBIO to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
2020-07-27,AVROBIO Sees Hammer Chart Pattern: Time to Buy?
2020-07-08,AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-07-06,AVROBIO Announces New Patients Dosed in Gaucher Disease and Cystinosis Clinical Trials
2020-06-29,AVROBIO Announces the Appointment of Kim Raineri as Chief Manufacturing and Technology Officer
2020-06-24,"Here is What Hedge Funds Think About AVROBIO, Inc. (AVRO)"
2020-05-14,AVROBIO Presents New Preclinical Data on Lentiviral Gene Therapy Program for Pompe Disease at ASGCT 2020
2020-05-13,AVROBIO Reports Updated Clinical Data from Investigational Gene Therapy Programs for Fabry Disease and Cystinosis
2020-05-09,We're Not Very Worried About AVROBIO's (NASDAQ:AVRO) Cash Burn Rate
2020-05-08,Why Earnings Season Could Be Great for AVROBIO (AVRO)
2020-05-07,AVROBIO Reports 1Q 2020 Financial Results and Provides Business Update
2020-05-06,AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-05-06,AVROBIO and Magenta Therapeutics Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate as a Potential Conditioning Regimen for Lentiviral Gene Therapies
2020-05-05,"AVROBIO to Present New Clinical and Preclinical Data at Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, May 12-15, 2020"
2020-05-04,AVROBIO to Collaborate with Saladax Biomedical on New High-Speed Diagnostic Assay Used with Busulfan Conditioning to Enable Widespread Commercialization of AVROBIOs Proprietary Platform Globally
2020-04-14,Is AVROBIO (AVRO) Stock a Solid Choice Right Now?
2020-04-12,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVROBIO, Inc. - AVRO"
2020-04-12,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVROBIO, Inc. - AVRO"
2020-04-03,AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-03-30,AVROBIO Outlines Response to COVID-19 and Current Assessment of Business Impact
2020-03-30,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of AVROBIO, Inc. - AVRO"
2020-03-26,AVROBIO to Participate in Upcoming April Investor Conferences
2020-03-25,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVROBIO, Inc. - AVRO"
2020-03-25,AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2020-03-19,"AVROBIO, Inc. (AVRO) Upgraded to Buy: What Does It Mean for the Stock?"
2020-03-17,"INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against AVROBIO, Inc. and Encourages Investors with Losses to Contact the Firm"
2020-03-17,"AVRO LOSS NOTICE: ROSEN, NATIONAL TRIAL LAWYERS, Announces Investigation of Securities Claims Against AVROBIO, Inc.  AVRO"
2020-03-17,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVROBIO, Inc. - AVRO"
2020-03-17,"AVRO Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AVROBIO, Inc. and Encourages Investors to Contact the Firm"
2020-03-16,AVROBIO Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update
2020-03-09,AVROBIO Receives Orphan Drug Designation from U.S. FDA for AVRRD04 for Cystinosis
2020-03-05,AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-02-24,AVROBIO to Present at the Cowen and Company 40th Annual Health Care Conference
2020-02-18,AVROBIO Announces Closing of Underwritten Public Offering
2020-02-12,AVROBIO Announces Pricing of Underwritten Public Offering of $100 Million of Common Stock
2020-02-12,AVROBIO Announces Proposed Public Offering of Common Stock
2020-02-11,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology"
2020-02-10,"AVROBIO Presents Positive Initial Data for its Investigational Cystinosis Program and Plato TM Platform, as well as Positive Data Out to 32 Months for its Ongoing Investigational Fabry Program"
2020-02-06,AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-02-04,AVROBIO Announces Clinical Data Presentation and Multiple Events at WORLDSymposium 2020
2020-01-14,AVROBIO Announces Clinical and Regulatory Progress for Gaucher Disease Program
2020-01-09,AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2019-12-19,AVROBIO Announces First Patient Dosed Using plato Platform
2019-12-16,AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2019-12-14,"Is AVROBIO, Inc. (AVRO) Going to Burn These Hedge Funds?"
2019-11-07,"AVROBIO, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update"
2019-11-06,"AVROBIO, Inc. (AVRO): Are Hedge Funds Right About This Stock?"
2019-10-24,AVROBIO Receives Orphan-Drug Designation from the U.S. FDA for AVRRD02 for the Treatment of Gaucher Disease
2019-10-22,AVROBIO Appoints Holly May as Chief Commercial Officer
2019-10-16,Here's Why We're Watching AVROBIO's (NASDAQ:AVRO) Cash Burn Situation
2019-10-08,AVROBIO Announces First Patient Dosed in Phase 1/2 Trial of Gene Therapy for Cystinosis
2019-10-03,"AVROBIO, Inc. to Present at Chardans 3rd Annual Genetic Medicines Conference"
2019-09-27,"AVROBIO, Inc. (AVRO) Upgraded to Buy: Here's What You Should Know"
2019-09-11,Moving Average Crossover Alert: AVROBIO
2019-08-29,"AVROBIO, Inc. to Present at Upcoming Investor Conferences"
2019-08-16,AVROBIO Appoints Georgette Verdin as Chief Human Resources Officer
2019-08-12,AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2019-08-08,AVROBIO Reports Second Quarter 2019 Financial Results and Provides Business Update
2019-08-08,3 Strong Buy Healthcare Stocks Insiders Are Buying Now
2019-08-06,"AVROBIO, Inc. to Present at the 2019 Wedbush PacGrow Healthcare Conference"
2019-07-29,3 Biotech Stocks Corporate Insiders are Buying
2019-07-26,Will AVROBIO Continue to Surge Higher?
2019-07-19,AVROBIO Announces Closing of Underwritten Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares
2019-07-18,Did Changing Sentiment Drive AVROBIO's (NASDAQ:AVRO) Share Price Down By 34%?
2019-07-17,"Why Seattle Genetics, AVROBIO, and First Majestic Silver Jumped Today"
2019-07-17,Here's Why Avrobio Rose as Much as 19.9% Today
2019-07-16,AVROBIO Announces Pricing of Underwritten Public Offering of $120.25 Million of Common Stock
2019-07-16,AVROBIO Announces Proposed Public Offering of Common Stock
2019-07-15,"Why Crocs, Golden Star Resources, and AVROBIO Jumped Today"
2019-07-15,AVROBIO Announces 87% Substrate Reduction in First Kidney Biopsy and Additional Positive Data from Clinical Trials of AVR-RD-01 Investigational Gene Therapy in Fabry Disease
2019-05-13,"AVROBIO, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update"
2019-05-12,"Heres What Hedge Funds Think About AVROBIO, Inc. (AVRO)"
2019-04-29,"AVROBIO, Inc. Announces FDA Clearance of Investigational New Drug Application for AVR-RD-01 Gene Therapy for the Treatment of Fabry Disease"
2019-04-26,AVROBIO Highlights the plato Platform and Gaucher and Cystinosis Programs at the 2019 Annual Meeting of the American Society of Gene and Cell Therapy
2019-03-25,"AVROBIO, Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update"
2019-03-05,"AVROBIO, Inc. to Present at the Cowen and Company 39th Annual Health Care Conference"
